Axogen director Kathy Johnson Weiler disposes of common shares worth $640.948,70PUBT·Aug 11 at 03:18 PMAXGN+0.29%
The Invisible AI Bottleneck: How Advanced Testing and Space Tech Are Redefining HardwareGlobal Report·Aug 11 at 04:43 AMAEHR-0.72%TER+2.47%
Why Axogen (AXGN) Is Up 6.9% After Raising 2026 Revenue Guidance Despite First-Half LossSimplywall·Aug 2 at 06:31 PMAXGN+0.29%
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in AxoGen, Inc. $AXGNMarket Beat·Aug 2 at 02:05 AMAXGN+0.29%
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter ReportSimplywall·Aug 1 at 10:12 AMAXGN+0.29%
Healthcare of Ontario Pension Plan Trust Fund Makes New Investment in AxoGen, Inc. $AXGNMarket Beat·Jul 31 at 04:01 AMAXGN+0.29%
AxoGen (NASDAQ:AXGN) Given New $55.00 Price Target at Citizens JmpMarket Beat·Jul 30 at 09:24 AMAXGN+0.29%
AXGN: Q2 revenue grew 23.1% year-over-year, driven by Breast market acceleration and strong Avance demandQuartr·Jul 29 at 09:11 AMAXGN+0.29%
Axogen | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 69.73 MEarnings Watch·Jul 29 at 06:14 AMAXGN+0.29%
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology | AXGN Stock NewsStockTitan·Jul 28 at 10:10 PMAXGN+0.29%
Axogen, Inc. Reports Second Quarter 2026 Financial Results | AXGN Stock NewsStockTitan·Jul 28 at 10:05 PMAXGN+0.29%
Axogen Q2 FY26 turns to net loss of USD 1.5 million; revenue rises 23.1% to USD 69.7 millionPUBT·Jul 29 at 06:07 AMAXGN+0.29%
